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Abstract
SynCAM1 is an adhesion molecule involved in synaptic differentiation and organization. SynCAM1 is also expressed in
astroglial cells where it mediates astrocyte-to astrocyte and glial-neuronal adhesive communication. In astrocytes, SynCAM1
is functionally linked to erbB4 receptors, which are involved in the control of both neuronal/glial development and mature
neuronal and glial function. Here we report that mice carrying a dominant-negative form of SynCAM1 specifically targeted
to astrocytes (termed GFAP-DNSynCAM1 mice) exhibit disrupted diurnal locomotor activity with enhanced and more
frequent episodes of activity than control littermates during the day (when the animals are normally sleeping) accompanied
by shorter periods of rest. GFAP-DNSynCAM1 mice also display high levels of basal activity in the dark period (the rodent’s
awake/active time) that are attenuated by the psychostimulant D,L-amphetamine, and reduced anxiety levels in response to
both avoidable and unavoidable provoking stimuli. These results indicate that disruption of SynCAM1-dependent astroglial
function results in behavioral abnormalities similar to those described in animals model of attention-deficit hyperactive
disorder (ADHD), and suggest a hitherto unappreciated contribution of glial cells to the pathophysiology of this disorder.
Citation: Sandau US, Alderman Z, Corfas G, Ojeda SR, Raber J (2012) Astrocyte-Specific Disruption of SynCAM1 Signaling Results in ADHD-Like Behavioral
Manifestations. PLoS ONE 7(4): e36424. doi:10.1371/journal.pone.0036424
Editor: Shu-min Duan, Zhejiang University School of Medicine, China
Received January 30, 2012; Accepted April 2, 2012; Published April 30, 2012
Copyright:  2012 Sandau et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the National Institutes of Health MH-77647 (JR), MH-65438, HD25123, and RR000163 for the operation of the
Oregon National Primate Research Center (SRO), NINDS [National Institute of Neurological Disorders and Stroke] R01 NS35884, a NARSAD [National Alliance for
Research on Schizophrenia and Depression] Independent Investigator Award, and a Development Disability Research Center Grant NIH P30-HD 18655 (Dr. Corfas).
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ojedas@ohsu.edu (SRO); raberj@ohsu.edu (JR)
¤ Current address: Legacy Research, Health Center, Legacy Emanuel Hospital, Portland, Oregon, United States of America
Introduction
SynCAM1 is a member of the immunoglobulin (Ig) superfamily,
a large group of proteins involved in cell surface recognition [1,2].
In vertebrates, four SynCAM genes, encoding highly conserved
intracellular and extracellular domains have been described [3].
One of these genes encodes SynCAM1, a protein originally
described as ‘‘tumor-suppressor in lung cancer 21’’ (TSLC1)
[4,5], and that is also known as nectin-like protein 3 (Necl2), or
Igsuperfamily4 (IGSF4). SynCAM1 plays an important role in
central nervous system development because it promotes synaptic
assembly [6], induces functional differentiation of presynaptic
terminals [7], enhances excitatory synaptic transmission [7,8],
mediates the organization of adhesive contacts between neuronal
growth cones and neurites [9], and maintains newly formed
excitatory synapses [10].
Although SynCAM1 is a major synaptic adhesive protein, we
recently found that SynCAM1 is also produced in astrocytes where
it plays a major role in facilitating astrocyte-to-astrocyte and
astrocyte-to-neuron adhesive communication [11]. We also
showed that SynCAM1 adhesive behavior is functionally coupled
to the tyrosine kinase receptor erbB4, a cell membrane protein
that recognizes neuregulin-1 as a ligand [12,13] and that is co-
expressed with SynCAM1 in astrocytes [11,14]. Ligand-dependent
activation of astrocytic erbB4 receptors results in a rapid, but
transient, increase in SynCAM1 adhesive behavior. Conversely,
disruption of astrocytic erbB4 receptor function leads to loss of
SynCAM1-mediated adhesiveness [11]. Because of our interest in
the neuroendocrine control of reproductive development, we
wanted to determine if astrocytic SynCAM1-dependent signaling
is required for normal female reproductive function. Therefore, we
generated transgenic mice that express – in an astrocyte-specific
manner – a dominant-negative form of SynCAM1 (GFAP-
DNSynCAM1) lacking the intracellular domain [14]. We observed
that female mice carrying this transgene had a delayed onset of
puberty, disrupted estrous cyclicity and reduced fecundity. These
deficits were associated with a reduced capacity of hypothalamic
astrocytes to respond to erbB4-mediated neuregulin stimulation
with release of prostaglandin E2, a key mediator used by astroglial
cells of the neuroendocrine brain to facilitate female reproductive
development.
During the course of these experiments, we noticed that GFAP-
DNSynCAM1 mice exhibited an unusually high level of activity,
which appeared unabated during the light period of the light cycle,
suggesting that their diurnal pattern of locomotor and/or sleep
activity was compromised. The mutant animals also appeared to
display a persistent, but aimless pattern of exploratory behavior in
a familiar environment. In addition, they exhibited increased
impulsivity as evidenced by a tendency to jump from the cage
when the lid was removed, and to attack other animals or the
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some of these alterations we subjected the animals to a battery of
behavioral tests measuring diurnal patterns of locomotor activity,
anxiety, motor coordination, and response to amphetamine
administration. The results of these analyses revealed that
GFAP-DNSynCAM1 mice display behavioral manifestations
previously observed in mouse models of attention deficit hyper-
active disorder (ADHD) [15,16]. Because GFAP-DNSynCAM1
animals have an astrocyte-specific defect in SynCAM1 signaling,
alterations in astrocyte function requiring adhesive-dependent cell-
cell communication might contribute to the neurodevelopmental
defects underlying the behavioral consequences of ADHD.
Materials and Methods
Animals
Male heterozygous mice that express an astrocyte-specific
dominant-negative form of SynCAM1 (GFAP-DNSynCAM1)
under control of the glial fibrillary acidic protein (GFAP) promoter
on the FvB/N background [14] were bred to either FvB/N or
C57BL/6 J wild-type (WT) females. Three independent transgen-
ic lines of GFAP-DNSynCAM1 mice (Lines 27, 42 and 45) were
used to generate offspring. Heterozygous adult male littermates
from Lines 27 (n=8) and 45 (n=6) and WT littermates (n=8)
were used to study changes in diurnal locomotor activity. The
animals employed were first generation (F1) adult male mice on an
outcrossed FvB/N6C57BL/6 J background. We used these F1
mice, because the FVB/N strain is homozygous for the retinal
degeneration 1 allele (Pde6b
rd1), which results in early onset retinal
degeneration. The F1 progeny of this cross would be expected to
recover normal retinal function while maintaining genetic
homogeneity between experimental mice. Although we observed
that mice maintained on the FvB/N background had a pattern of
locomotor activity similar to that of the F1 animals (data not
shown), we used F1 animals for all experiments assessing diurnal
changes in locomotor activity. The F1 mice were weaned at 21
days of age and housed with littermates of both genotypes until
they were 4–5 months old. Thereafter, they were separated into
individual housing 3 days prior to implantation surgery, and
remained individually housed until completion of the study. Line
42 adult male mice (n=8) and WT littermates (n=9) maintained
on the original FvB/N background were used for all other
behavior tests. We employed L42 animals for these tests because in
our initial characterization of the mutants we found that the
GFAP-DNSynCAM1 transgene was more abundantly expressed
in areas of the brain more relevant to behaviors of interest than the
hypothalamus. Thus, L42 mice were expected to be a better model
for behavioral alterations than L45 and 27 in which the DN-
SyCAM1 transgene is more abundantly expressed in the
hypothalamus than the rest of the brain. L42 male pups were
weaned at 21 days of age and housed with littermates of the same
genotype until 4–5 months of age. Due to the aggressive
tendencies of the GFAP-DNSynCAM1 mice, WT males were
kept separate from mutant males to avoid potential fear
conditioning prior to testing. All animals were single housed
throughout the duration of the tests. Genotyping was carried out
using PCR protocols previously described [14]. The animals were
housed under a 12:12 h light - dark cycle (lights on at 0600) and
given free access to food and water. All experiments were
conducted in accordance with NIH guidelines and approved by
the Oregon National Primate Research Center/Oregon Health &
Science University Institutional Animal Care and Use Committee.
Behavioral Tests
Adult male mice were tested for (i) diurnal activity using
MiniMitter implantation devices (MiniMitter, Sun River, Oregon);
(ii) spontaneous locomotor activity and altered amphetamine
response using the open field test and infrared photo beams
(Kinder Scientific, Poway, California); (iii) measures of anxiety
involving avoidable anxiety-provoking stimuli using the elevated
zero maze test (Kinder Scientific) and (iv) measures of anxiety
involving unavoidable anxiety-provoking stimuli induced by
acoustic stimuli in sound-attenuated acoustic startle chambers
(Kinder Scientific). DN-SynCAM1 mice were also tested for
deficits in sensorimotor function on a rotarod, and learning and
memory using contextual and cued fear conditioning tests, as
described below in detail.
Tests ii-iii were conducted in the following order: Week 1 –
elevated zero maze, rotarod, acoustic startle, and pre-pulse
inhibition; Week 2 – cued and contextual fear conditioning; Week
3 - no behavior testing, animals remained in the home cage, but
were handled daily by the investigator; Week 4 - spontaneous
locomotor activity and response to amphetamine.
Mini Mitter
To assess changes in diurnal activity in the home cage, mice
were implanted under isoflurane anesthesia with pre-calibrated
sensitive transmitters (PDT-4000 G2 E-MitterH sensors, Mini
Mitter Company, Sun River, OR). E-Mitters were implanted
beneath the interscapular brown adipose tissue adjacent to the
right scapula. The devices were secured to muscle tissue with a
single suture, and wounds were closed with MikRon stainless steel
wound clips. For the actual experiment, the mice were moved
from the colony room to a separate isolated study room. Both
rooms shared the same 12-hour light cycle. Human activity in the
room was limited to necessary husbandry and technician duties.
Mice were allowed 1 week of recovery and acclimation to the new
environment before studies commenced. Mouse activity was then
recorded for 1 week. Cages were not changed during these 2 weeks
so that the mice would not be disturbed. Signals emitted by the E-
Mitter transmitters were detected by a receiver positioned
underneath the animal’s home cage and converted into activity
counts (arbitrary units) by VitalViewH software (Mini Mitter).
Locomotor activity counts measured this way are a relative
measure of gross motor activity. For all experiments, activity
counts and interscapular temperature measurements were record-
ed every 6 minutes. Activity count data was calculated as
cumulative activity per 6-minute interval. Temperature data was
also recorded and calculated by the VitalViewH software using a
weighed time-averaged ‘‘bin’’ based on sample data points taken
at 6-minute intervals. All temperature data points more than one
standard deviation away from the mean were discarded by the
software. Once data collection was complete, the raw data was
exported from VitalViewH in the form of a delimited ASCII file
and imported into a Microsoft Excel spreadsheet for further
analysis.
Open Field
Spontaneous locomotor activity and response to amphetamine
was assessed in the open field arena over three periods:
habituation, saline injection and amphetamine injection. The
open field arena (16 inch616 inch square) was equipped with a
16616 array of infrared photocells for measuring horizontal
movements and computer-quantified automatically (Kinder Sci-
entific, Poway CA). The open field test was conducted during the
active (lights out) period of the animal’s 12:12 cycle, starting at the
time of lights off. Animals were placed into the open field arena for
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received a subcutaneous saline injection (volume matching that of
the subsequent amphetamine injection) and returned to the open
field for 2 consecutive hours to assess locomotor activity in
response to a vehicle injection. After the saline trial, animals
received a subcutaneous injection of D,L- amphetamine (4 mg/kg)
and were returned to the open field to assess their response to
amphetamine. The animals were tested in their own dedicated
chambers for the duration of the night and were not disturbed
during testing periods. After each trial, the open field arena was
cleaned with 0.5% acetic acid. During this time, the animals were
returned to their home cage for no more than a 5-minute period.
The total distance traveled by each animal during each period was
analyzed to determine the activity levels.
Elevated Zero Maze
Measures of anxiety involving avoidable anxiety-provoking
stimuli were assessed using the elevated zero maze. The elevated
zero maze consisted of two enclosed areas (safe environments) and
two open areas (anxiety-provoking environment), identical in
length (35.5 cm; Kinder Scientific, Poway, CA). The elevated zero
maze was equipped with infrared photocells for measuring
horizontal movements and computer-quantified automatically
(Kinder Scientific, Poway CA). Mice were placed into the maze
facing the enclosed area at a site where the enclosed and open
areas interfaced. The mice were allowed free access to the maze
for 5 min. The software calculated the total distance moved;
distance moved in both the enclosed and open areas; and time
spent active and resting in the enclosed and open areas of the
maze.
Acoustic Startle
Measures of anxiety involving unavoidable acoustic stimuli were
assessed using the acoustic startle behavioral paradigm. Animals
were placed in a plexiglass enclosure on a sensing platform within
a sound-attenuating chamber (Kinder Scientific, Poway, CA).
After a 5-min acclimation, the baseline response was measured in
three trials. Animals were then exposed to pulses of white noise
administered in increments of 2 db, from 80–120 db within a
500 msec window, and the maximum force of the mouse on the
sensing plate was measured in newtons (N). Startle amplitude was
defined as the peak voltage force that occurred during the
500 msec record window. Wideback background noise (72 db)
was used during testing. For each trial, the startle amplitude was
computer-quantified automatically using Kinder Scientific soft-
ware (Poway, CA).
Rotarod
Sensorimotor performance was assessed on a Rotarod. Mice
were placed on an elevated rotating rod (diameter: 3 cm, elevated:
45 cm, Rotamex-5, Columbus Instruments, Columbus, OH),
initially rotating at 5.0 RPM. The rod accelerated 1.0 RPM every
3 seconds. A line of photobeams beneath the rod recorded the
latency to fall(s). Each mouse received three trials per day, with no
delay between trials, on three consecutive days.
Fear Conditioning
The mice were tested for fear conditioning using Med
Associates NIR Video and automated analysis (Med Associates,
St. Albans, Vermont) utilizing Med Associates Video Freeze
automated scoring system. In this task, mice learn to associate a
conditioned stimulus (CS, e.g. a tone) with a mild foot shock
(unconditioned stimulus, US). CS-US pairings are preceded by a
short habituation period, from which a baseline measure of
locomotor activity and other behavior can be scored. Post-
exposure freezing, defined as absence of all movement with the
exception of respiration, is a widely used indictor of a conditioned
fear response. On day 1, the mice were placed inside a white LED
lit (100 lux) fear conditioning chamber (Context A). There was a
150 second baseline followed by two CS-US pairings. A 2.8 kHz,
80 dB tone (CS) was presented at 150 and 270 seconds. Both CS
presentations co-terminated with a 2-sec 0.35 mA footshock (US).
On day 2, hippocampus dependent associative learning was
assessed during re-exposure to Context A for 300 seconds. Three
hours later, mice were exposed to Context B. Context B contained
a smooth white floor, a black plastic triangular insert for the walls,
scented with vanilla. The mice were allowed to habituate for
180 seconds (Pre-CS period), and then exposed to the tone for a
second period of 180 seconds (Post-CS period). Associative
learning was measured as the percent time spent freezing in
response to the contextual environment or tone. Motion during
shock (arbitrary units) was measured to explore potential genotype
differences in response to the aversive stimulus.
Pre-pulse inhibition (PPI)
Mice were placed in an enclosure within a startle monitor
sound-attenuated chamber and startle response amplitudes were
measured with a force transducer (Kinder Scientific, Poway, CA).
Following a 5 min acclimation period, mice were exposed to 3,
40 ms acoustic stimuli (110 db). The testing phase consisted of
20 ms pre-pulses (70–80 db) followed by 50 ms delays and 40 ms
acoustic stimuli (110 db). The same pattern of acoustic stimuli and
testing with pre-pulses then occurred with a 120 db stimulus.
Random inter-trial intervals were used between trials (15–30 sec).
PPI was calculated using the following formula: % respons-
e=1006(S-PS)/S), where S was the mean startle amplitude
without a pre-pulse and PS was the mean startle response
following a pre-pulse. Thus, a 100% response in the PPI test
indicates complete inhibition of the startle response during pre-
pulse trials.
Statistical Analyses
All statistical analyses were performed using Statview software
version 5.0.1 (SAS Institute Inc, Cary, NC) or GraphPad Prism
software (GraphPad Software, La Jolla, CA). Two way ANOVAs
were used for analysis of the diurnal activity data using genotype as
between-subject factor and light/dark cycle as within-subject
factor. To analyze the open field data and acoustic startle data,
repeated measures ANOVAs were performed using genotype as a
between-subject factor and time post injection or stimulus intensity
(db) as the within-subject factor. Depending on the outcome of the
ANOVA analysis, post-hoc tests were used when appropriate. T-
test was used for analysis of the elevated zero maze data. Data
were expressed as means 6 SEM. p,0.05 was considered
significant for all tests.
Results
GFAP-DNSynCAM1 mice show signs of increased
impulsivity
Throughout the duration of the study, we observed (but did not
quantify) behavioral features in GFAP-DNSynCAM1 mice
suggestive of increased impulsivity. They had a tendency to jump
from the cage upon removal of the cage’s lid. They also appeared
more aggressive as they attacked other mice without provocation
and persistently attempted to bite the hand of investigators and
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was necessary to always wear a Kevlar glove when handling them.
GFAP-DNSynCAM1 mice display increased home cage
activity and attenuation of changes in diurnal rhythm
activity
Twenty four-hour home cage activity of two independent lines
of GFAP-DNSynCAM1 (L27 and L45) mice and WT littermate
controls was recorded using implanted MiniMitter devices for a
period of one week. WT mice exhibited a diurnal rhythm of
locomotor activity characterized by a decrease in spontaneous
activity with a corresponding increase in the duration of resting
periods (the interval between activity peaks) during the light phase
as compared to the dark phase (Fig. 1A, upper panel). The activity
profiles of GFAP-DNSynCAM1 mice were strikingly different,
showing more pronounced episodes of activity during the light
phase than WT controls (Fig. 1A, middle and lower panels). The
mutant mice had a significant increase in total daily activity during
the light phase compared to WT littermates (F=17.04; p,0.0001)
(Fig. 1B). They also exhibited a significant (F=36.33; p,0.0001)
increase in the amplitude of activity peaks during this phase of the
light cycle (Fig. 1C). In contrast to WT mice, in which the peak
amplitude of each activity episode was significantly (p,0.0001)
higher at night than during the day, GFAP-DNSynCAM1 mice
showed no differences in peak amplitude between the light and
dark phase of the light cycle (Fig. 1C). Episodes of activity during
the light phase occurred more frequently (F=4.45; p=0.019)i n
the mutant mice than in WT animals (Fig. 1 D). The transgenic
mice also spent significantly (F=3.35; p,0.047) less total time
resting than WT animals during the light phase (Fig. 1E), and
their rest periods were of a shorter (F=3.82; p,0.031) duration
(Fig. 1F). Average hourly body temperature showed a diurnal
pattern that was similar between GFAP-DNSynCAM1 mice and
WT controls. In both cases, body temperature began to increase
by 16:00 h, andreached peak levels within the first two hours of
the dark phase (Fig. 2). The peak occurred one hour sooner in the
mutant mice than in WT littermates (Fig. 2).
GFAP-DNSynCAM1 mice exhibit increased spontaneous
locomotor activity in the open field that is attenuated by
amphetamine
Spontaneous locomotor activity of GFAP-DNSynCAM1 mice
was tested during the active (dark) phase of the animal’s cycle as
illustrated in Fig. 3A. During the 4-h habituation period the
mutant and WT littermates had similar activity levels. However,
upon injecting the animals with saline and returning them to the
open field (Saline 2 h), the transgenic mice showed an increase in
locomotor activity (Fig. 3B, C). This increase was sustained
throughout the 2 h period studied (Fig. 3C), with values
significantly higher (F=7.66; p=0.011) in GFAP-DNSynCAM1
as compared to WT mice during both the first and the second
hour following saline injection (Fig. 3B, inset). The increase in
activity shown by GFAP-DNSynCAM1 mice occurred indepen-
dent of significant changes in sensorimotor function (measured
using an accelerating rotarod), potential deficits in learning and
memory (assessed using contextual and cued fear conditioning
paradigms) or alterations in acoustic startle or pre-pulse inhibition
(data not shown).
To determine if the increased locomotor activity of GFAP-
DNSynCAM1 mice was associated with an altered response to
amphetamine, mice were administered a single subcutaneous
injection of the drug (4 mg/kg) and immediately returned to the
familiar open field arena. Across the 2 h testing period there was a
highly significant genotype by time bin effect (F=5.88; p,0.0001;
Fig. 3D). In the first 10 min time bin the GFAP-DNSynCAM1
mice had a significant (p,0.025) increase in total distance traveled
compared to the WT littermates, which is in accord with the
baseline activity measurements shown in Fig. 3B. However, by
30 minutes after amphetamine the GFAP-DNSynCAM1 mice
began to respond to amphetamine with a decrease in total distance
traveled; in contrast, WT littermates responded to amphetamine
with increased locomotor activity (Fig. 3D). This altered response
to amphetamine in the transgenic mice was significantly (p,0.05)
different from the response of WT littermates between 50 and
80 minutes post injection. After this interval, activity levels in both
genotypes began to return to baseline.
GFAP-DNSynCAM1 mice have decreased measures of
anxiety
In addition to an increase in spontaneous locomotor activity and
altered response to amphetamine, transgenic mouse models of
ADHD have either reduced or unchanged measures of anxiety
[17,18]. Thus, we sought to determine if GFAP-DNSynCAM1
mice exhibit changes in measures of anxiety using paradigms
involving avoidable and unavoidable anxiety-provoking stimuli.
Transgenic and WT type littermates were first tested in the
elevated zero maze (Fig. 4). GFAP-DNSynCAM1 showed
reduced measures of anxiety. They travelled a longer distance
(p=0.031; Fig. 4A) and had increased active (p=0.035) and rest
times (p=0.045) within the open areas, as compared to the WT
controls (Fig. 4B and C). Conversely, the total distance traveled
in both the open and closed areas was similar in the transgenic and
WT littermates (Fig. 4D).
The GFAP-DNSynCAM1 mice also displayed reduced mea-
sures of anxiety in the acoustic startle test. Across all stimulus
intensities tested there was a significant genotype effect (F=6.33;
p=0.0258) showing a lower startle amplitude in the GFAP-
DNSynCAM1 mice compared to the WT controls (Fig. 5A).
Subsequent analysis of the average startle amplitudes for the WT
and DN-SynCAM1 mice at baseline (0 db) versus all other
stimulation intensities (80–120 db) indicated a genotype6stimula-
tion condition interaction (F=26.16; p=0.0002; Fig. 5B). While
there was a significant reduction (p,0.05) in the average startle
amplitude in the GFAP-DNSynCAM1 mice within the 80–120 bd
range compared to WT controls, there was no difference in the
two groups at 0 db. Finally, we assessed the GFAP-DNSynCAM1
mice for deficits in sensorimotor gating using the PPI test. The
percent response to an acoustic startle (110 or 120 db) following a
pre-pulse was not significantly different in the GFAP-DNSyn-
CAM1 mice compared to the WT controls (Fig. 5C).
Discussion
The present results demonstrate that an alteration of glial
biology caused by loss of SynCAM1-dependent signaling specif-
ically targeted to astrocytes results in behavioral manifestations
previously observed in rodent models of ADHD. The increased
impulsivity, disruption of the light-dark patterns of locomotor
activity, and the paradoxical calming effect of the pysochostimu-
lant amphetamine on hyperactivity are all hallmarks of ADHD
[15,16,19], and are all observed in mutant mice with disrupted
astroglial SynCAM1 function.
ADHD is a highly heritable condition that affects 6–9% of
children and that is characterized by three main behavioral
abnormalities: hyperactivity, impulsivity and impaired sustained
attention [15,19]. Although ADHD is considered a neurodevel-
opmental disorder of childhood [20], its manifestations persist well
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mice, is consistent with this concept. The precise etiology of
ADHD remains elusive, but genetic analyses of affected human
populations have shown association of ADHD with mutations in
several genes involved in synaptic transmission, and specifically
with genes encoding components of the monoaminergic neuro-
transmitter system. Prominent among these genes are SNAP25,
which encodes a presynaptic protein required for neurotransmitter
release [21,22], DRD2, the gene encoding dopamine (DA)
receptors of the 2 subtype [23], and DAT1 [22,24,25], which
encodes a dopamine transporter responsible for clearing DA
released into the synaptic cleft during synaptic activity. The
serotonin receptor 5HT1b and serotonin transporters have also
been implicated [17,22,26].
The genetics of ADHD [22,24,26], and results obtained using
mouse models of the disorder [15,16], support the concept that
impairments in synaptic neurotransmission are a major underlying
cause of most ADHD manifestations. Nevertheless, none of the
available mouse models have provided data free of inconsistencies,
suggesting the existence of additional mechanisms independent of
a primarily neuronal impairment in synaptic transmission. For
instance, the high blood pressure observed in spontaneous
hypertensive rats (SHR), the most widely used animal model of
ADHD, is not a feature of ADHD. When hypertension is
eliminated as a confounding factor by crossing SHR rats to
Figure 1. GFAP-DNSynCAM1 mice have increased locomotor activity and shortened resting intervals during a 24 h period. Adult
male GFAP-DNSynCAM1 L27 (n=8), L45 (n=6) mice and WT littermates (n=8) were housed individually and 24-hour activity was recorded in 6-
minute bins for a period of one week using MiniMitter telemetry devices. (A) Representative 24-hour activity profiles from one WT littermate (upper
panel) and two GFAP-DNSynCAM1 adult male mice (Line 27, middle panel; L45, lower panel). (B) Average cumulative daily activity counts for both
light and dark periods. (C) Average amplitude of activity spikes during light and dark periods (number of activity counts per 6-minute bin). (D)
Average frequency of activity peaks (minutes) for light and dark periods. (E) Average cumulative time spent resting (minutes) during light and dark
periods (6-minute bins recorded as zero movement). (F) Average duration of each rest period (minutes) for both light and dark periods. Activity was
analyzed in the light and dark periods for WT (white bars), DN-SynCAM1 L27 (grey bars) and DN-SynCAM1 L45 (black bars). For all graphs data are
expressed as the mean 6 SEM. Data are analyzed using a two way ANOVA (period by genotype) followed by Student-Newman-Keuls post hoc
analysis, * p,0.05; ** p,0.01; *** p,0.001.
doi:10.1371/journal.pone.0036424.g001
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but no longer responds to the psychostimulant methylphenidate
with decreased hyperactivity [27]. The Coloboma mouse, another
frequently used mouse model of ADHD, has mutations in the
genes encoding SNAP-25 and phospholipase C-b1 [15,16], and
exhibit profound hyperactivity, which is reduced by amphetamine,
but not by methylphenidate [21]. Mice lacking the DA transporter
DAT1 respond to both amphetamine and methylphenidate with
decreased hyperactivity, but surprisingly this effect occurs even
when these animals lack DAT, a protein shown by other studies to
be a major target for both stimulants [15,16].
Thus, additional molecules and other mechanisms may
contribute to the physiopathology of ADHD. Without negating
the importance of pure impairments in neurotransmission, our
results suggest that the astrocyte-specific loss of SynCAM1-
mediated signaling is a contributing factor. Neurons may not be
directly affected in GFAP-DNSynCAM1 mice, because mutations
in CADM1 (the SynCAM1 gene in humans) that cause morpho-
logical abnormalities in neurons and defects in synaptogenesis, are
not associated to ADHD, but instead appear to contribute to the
molecular pathogenesis of autism spectrum disorder [28]. This is
an important consideration because the construct we employed to
target mutant SynCAM1 to astrocytes is driven by the GFAP
promoter, and GFAP has been shown to be expressed in neural
progenitor cells of the adult mouse forebrain [29]. In fact, GFAP-
expressing progenitor cells have been shown to be responsible for
the bulk of constitutive neurogenesis in the adult brain [29].
However, in other studies using transgenes driven by the same
GFAP promoter we did not observe changes in a variety of basic
physiological parameters of neuronal function [30]. Another cell
type expressing a polysialylated form of SynCAM1 is the NG2
cells [31], which are scattered throughout the brain and give rise to
oligodendrocytes, astrocytes, and neurons. Since these cells do not
express GFAP, it unlikely that they may have been directly
affected in the GFAP-DNSynCAM1 mice. Thus, the effects we
observe appear to be specific to alterations in astrocytic SynCAM1
function.
In addition to ADHD-like impairments, GFAP-DNSynCAM1
mice exhibit reduced measures of anxiety, and increased
impulsivity, two features observed in serotonin receptor 5HT1B
KO mice [17], another model of ADHD. Although co-morbid
anxiety conditions are common in children with ADHD [19], they
do not constitute an integral feature of the disorder. Instead,
animal studies suggest that measures of anxiety are either reduced
[17] or unchanged [18] in ADHD.
The disruption in diurnal rhythms of activity observed in
GFAP-DNSynCAM1 mice is characterized by more frequent and
intense episodes of activity during the day – when the animals are
normally sleeping – accompanied by more infrequent and shorter
periods of rest. Although we did not evaluate sleep architecture
directly, this disrupted pattern of diurnal activity strongly suggests
that GFAP-DNSynCAM1 mice might also suffer from sleep
disturbances, another hallmark of ADHD [19]. An involvement of
astroglial cells in sleep regulation is now well established.
Astrocytes control sleep homeostasis by releasing ATP, which is
cleaved into adenosine [32] a purine nucleoside that promotes
sleep [33]. Astrocytes play a further role in regulating extracellular
adenosine concentrations through passive reuptake of adenosine
followed by adenosine kinase-mediated intracellular phosphoryla-
tion of adenosine to adenosine-59-monophosphate (AMP) [34].
This regulatory effect is likely to have a diurnal periodicity because
ATP is released from astrocytes in a circadian fashion [35]. In
humans, sleep disturbance associated with ADHD have been
ascribed to polymorphism of the DNA sequence encoding the 39
untranslated region of the CLOCK gene [36,37], a gene essential
for circadian periodicity [38,39].
The ADHD-like manifestations of GFAP-DNSynCAM1 mice
may be due to an inability of astrocytes to communicate with other
astrocytes and neurons via adhesive-mediated signaling. Like
many other adhesion molecules of the immunoglobulin superfam-
ily [2], SynCAM1 is capable of signal transduction. Its intracel-
lular domain contains both a FERM binding motif and a C-
terminus sequence recognized by proteins containing PDZ
domains type II [3,40]. Binding of membrane associated proteins
(such as protein 4.1, calcium/calmodulin-dependent serine protein
kinase [CASK] and syntenin) to these domains, link SynCAM1 to
signaling events associated with the structural re-organization of
the cytoskeleton [40,41]. The FERM domain also recruits NMDA
and AMPA receptors for excitatory neurotransmission [42].
Because astrocytes express both metabotropic glutamate and
Figure 2. Average 24-hour body temperature profiles. F1 adult male GFAP-DNSynCAM1 L27 (n=8), L45 (n=6) mice and WT littermates (n=8)
of an FvB/N6C57BL/6 J background were housed individually and 24-hour body temperature was recorded in 6-minute weighted time-averaged
bins for a period of one week using MiniMitter telemetry devices. The mutant mice have a 1-hour phase shift relative to WT littermates in the peak of
body temperature increase that occurs as the animals enter the dark phase.
doi:10.1371/journal.pone.0036424.g002
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mediated glia-to-neuron signaling events [43,44], it is possible that
a defect in astroglial SynCAM1 function results in ADHD-like
behaviors because of an alteration in excitatory glia-to-neuron
communication. This notion is supported by the finding that Grin1
mutant mice, which carry a mutation of the NMDA receptor
subunit 1, exhibit ADHD-like enhanced locomotor activity that is
methyphenidate-sensitive [18]. Alterations of glutamatergic trans-
mission in ADHD are further suggested by the reduction in
glutamate release observed in cortical synaptosomes from Colo-
boma hyperactive mice [45]. A role for astrocytes in this process is
implied by the well- established contribution of astrocytes to the
regulation of excitatory neurotransmission [46,47].
We earlier observed that SynCAM molecules cluster in both
astrocytes and neurons as a result of erbB4 receptor activation
[14], leading to the formation of ‘‘hot-spots’’ of cell adhesion and
signaling domains. These domains may contribute to the dynamics
of receptor distribution that occurs in both neurons and astrocytes
in response to changes in cell activity. Their formation also appear
to require CASK, because CASK is recruited by SynCAM1 to the
cell membrane [6], promotes cytoskeleton reorganization [48],
sorts NMDA receptors [49], and interacts with N- and P/Q-type
of voltage-gated calcium channels [50,51]. Thus, SynCAM1 may
act on astrocytes not only to regulate cell plasticity, but also to
facilitate calcium influx and release of excitatory neurotransmit-
ters.
Although astrocytic SynCAM1 is functionally linked to erbB4
Figure 3. GFAP-DNSynCAM1 mice have increased spontaneous
locomotor activity that is attenuated by amphetamine. (A)
Illustration depicting the behavior paradigm used to assess spontane-
ous locomotor activity and response to amphetamine in the open field.
Adult male GFAP-DNSynCAM1 (n=8) and WT littermates (n=5) were
subjected to the following paradigm during the dark (active) phase of
the light cycle: 4 h of habituation, followed by 2 h of spontaneous
locomotor activity post saline injection, followed by 2 h of locomotor
activity after injection of D,L- amphetamine (4 mg/kg). (B) Total
distance traveled (cm) in 1 hour time bins by GFAP-DNSynCAM1 (black
circles) and WT littermates (white squares) during the habituation
period. (C) Total distance traveled (cm) in 10 minute time bins by GFAP-
DNSynCAM1 (black circles) and WT littermates (white squares)
immediately following a subcutaneous injection of saline. Inset is the
average distance traveled (cm) by each mouse during the first and
second hours of behavior assessment. (D) Total distance traveled (cm)
in 10 min bins by GFAP-DNSynCAM1 (black circles) and WT littermates
(white squares) immediately following a subcutaneous injection of D,L-
amphetamine (4 mg/kg). For all graphs the data points are represented
as means 6 SEM. Panels B–D were analyzed using a repeated measures
ANOVA (time by genotype) followed by an unpaired t-test for each time
point (panel D). Data shown in the inset to panel C were analyzed by a
two way ANOVA (time by genotype) followed by a Student-Newman-
Keuls post hoc test. * p,0.05.
doi:10.1371/journal.pone.0036424.g003
Figure 4. DN-SynCAM1 mice display behaviors of reduced
anxiety in the zero maze. (A) Total distance traveled (cm) by GFAP-
DNSynCAM1 (black bars; n=9) and WT littermates (white bars, n=8) in
the open areas of the zero maze. (B) Total active time (seconds) in the
open areas for GFAP-DNSynCAM1 (black bars) and WT littermates
(white bars). (C) Total rest time (seconds) in the open areas for GFAP-
DNSynCAM1 (black bars) and WT littermates (white bars). (D) Total
distance traveled in the open and closed areas of the zero maze by
GFAP-DNSynCAM1 (black bars) and WT littermates (white bars). Data
are represented as the mean 6 SEM and compared using an unpaired t-
test. * p,0.05.
doi:10.1371/journal.pone.0036424.g004
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signaling have been associated to the physiopathology of
schizophrenia [[52,53] and references therein], we did not observe
differences in PPI between GFAP-DNSynCAM1 mice and their
WT littermates. PPI of the acoustic startle response, a measure of
sensorimotor gating, is widely used in rodent models of
schizophrenia, because it is consistently diminished in schizo-
phrenic patients [54]. Since we measured PPI only under basal
conditions, we cannot exclude the possibility that a schizophrenia-
like behavior would have been unveiled in DN-SynCAM1 mice
treated with amphetamine [55,56].
Altogether, our findings support the concept that SynCAM1-
dependent deficiency in astrocytic function contribute to the
physiopathology of ADHD. They also suggest that the behavioral
manifestations caused by these deficiencies result from an inability
of astrocytes to establish functional avenues of cell-cell commu-
nication with relevant neuronal networks. Future studies are
warranted to determine the age at which these behavioral
impairments are initiated, the cellular mechanisms involved, and
whether increasing astrocytic SynCAM1 levels can reduce or even
prevent ADHD-like behaviors.
After our manuscript was accepted we became aware of a paper
by Shamir A et al. (J.Neuroscience 32:2988–2997, 2012) reporting
very similar behavioral phenotypes in mice lacking the ErbB4
receptor.
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Figure 5. GFAP-DNSynCAM1 mice have reduced anxiety in the acoustic startle paradigm. (A) Startle amplitudes for the GFAP-
DNSynCAM1 (black bars; n=8) and WT (white bars; n=7) mice for each of the sound intensities tested. Data points represent means 6 SEM. Data
were analyzed with ANOVA for repeated measures. (B) The average startle amplitudes for each genotype during baseline (0 db) and after different
stimulation intensities (80–120 db). (C) Percent response of GFAP-DNSynCAM1 (black bars; n=9) and WT (white bars; n=8) in the PPI test using two
different stimuli intensities (110 and 120 db). The data are represented as the mean 6 SEM and analyzed by two- way ANOVA (intensity by genotype)
followed by unpaired t test post hoc analysis. * p,0.05.
doi:10.1371/journal.pone.0036424.g005
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